Mitsubishi Tanabe Pharmaceuticals To Merge Two Subsidiaries
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharmaceuticals announced July 8 that its two wholly owned subsidiaries, Osaka-based MP Technopharma and Yamaguchi-based Tanabe Yamaguchi Seiyaku will merge, effective October 1. The move aims to strengthen production functions and boost efficiency as a group. (Click here for more - Japanese language)